The efficacy of regorafenib monotherapy as the third-and later-line treatment for metastatic colorectal cancer: a retrospective study
[Objectives] To investigate the efficacy and safety of regorafenib monotherapy as the third-and later-line treatment for metastatic colorectal cancer. [Methods] This was a retrospective analysis of 32 patients with metastatic colorectal cancer receiving regorafenib monotherapy as the third-and later...
| الحاوية / القاعدة: | 结直肠肛门外科 |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | مقال |
| اللغة: | الصينية |
| منشور في: |
Editorial Office of Journal of Colorectal & Anal Surgery
2022-08-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=377&cateName=2022%E5%B9%B4%20%E7%AC%AC28%E5%8D%B7%20%E7%AC%AC4%E6%9C%9F |